| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 38 | 2026 | 668 | 9.950 |
Why?
|
| Regeneration | 16 | 2026 | 230 | 5.190 |
Why?
|
| Heart | 16 | 2026 | 650 | 5.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 13 | 2026 | 619 | 4.480 |
Why?
|
| Cell Cycle Proteins | 14 | 2026 | 710 | 3.760 |
Why?
|
| Myocardial Infarction | 13 | 2025 | 999 | 3.510 |
Why?
|
| Fibroblasts | 8 | 2025 | 849 | 2.640 |
Why?
|
| Organogenesis | 8 | 2025 | 75 | 2.370 |
Why?
|
| Signal Transduction | 23 | 2026 | 4686 | 2.260 |
Why?
|
| Transcription Factors | 13 | 2026 | 2406 | 2.210 |
Why?
|
| Homeodomain Proteins | 5 | 2019 | 555 | 2.100 |
Why?
|
| Cell Proliferation | 20 | 2026 | 2465 | 1.890 |
Why?
|
| Animals | 85 | 2026 | 33912 | 1.860 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2026 | 484 | 1.850 |
Why?
|
| Phosphoproteins | 7 | 2019 | 448 | 1.770 |
Why?
|
| Heart Diseases | 6 | 2019 | 499 | 1.670 |
Why?
|
| Gene Expression Regulation, Developmental | 13 | 2026 | 950 | 1.660 |
Why?
|
| MicroRNAs | 11 | 2018 | 889 | 1.590 |
Why?
|
| Mice | 51 | 2026 | 18301 | 1.440 |
Why?
|
| Myocardium | 11 | 2025 | 852 | 1.440 |
Why?
|
| Single-Cell Analysis | 6 | 2025 | 350 | 1.270 |
Why?
|
| Transcriptome | 8 | 2025 | 1103 | 1.250 |
Why?
|
| Dependovirus | 4 | 2025 | 160 | 1.150 |
Why?
|
| Cell Cycle | 5 | 2026 | 594 | 1.130 |
Why?
|
| Fibrosis | 5 | 2025 | 429 | 1.120 |
Why?
|
| Actins | 2 | 2024 | 321 | 1.100 |
Why?
|
| Sinoatrial Node | 2 | 2020 | 28 | 1.060 |
Why?
|
| Mitochondria | 3 | 2024 | 785 | 1.020 |
Why?
|
| Cell Nucleus | 2 | 2021 | 556 | 1.020 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2025 | 161 | 0.970 |
Why?
|
| Cardiomyopathies | 5 | 2026 | 514 | 0.950 |
Why?
|
| Mutagenesis, Insertional | 2 | 2026 | 150 | 0.940 |
Why?
|
| Genetic Therapy | 4 | 2025 | 713 | 0.930 |
Why?
|
| Mice, Knockout | 20 | 2026 | 3819 | 0.920 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2026 | 74 | 0.900 |
Why?
|
| Stress, Mechanical | 1 | 2026 | 178 | 0.900 |
Why?
|
| Skull | 3 | 2022 | 149 | 0.900 |
Why?
|
| Hedgehog Proteins | 1 | 2026 | 199 | 0.890 |
Why?
|
| Heart Neoplasms | 1 | 2026 | 106 | 0.870 |
Why?
|
| Glycolysis | 1 | 2025 | 174 | 0.860 |
Why?
|
| Atrial Fibrillation | 5 | 2025 | 738 | 0.860 |
Why?
|
| Cell Differentiation | 17 | 2025 | 1928 | 0.850 |
Why?
|
| Mitochondrial Dynamics | 1 | 2024 | 56 | 0.810 |
Why?
|
| Neural Crest | 2 | 2015 | 52 | 0.800 |
Why?
|
| Ependymoglial Cells | 2 | 2019 | 12 | 0.760 |
Why?
|
| Bone Morphogenetic Protein 4 | 2 | 2013 | 42 | 0.740 |
Why?
|
| Chromatin | 4 | 2025 | 499 | 0.740 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2019 | 37 | 0.720 |
Why?
|
| Pre-Eclampsia | 4 | 2019 | 226 | 0.710 |
Why?
|
| Endothelial Cells | 5 | 2026 | 523 | 0.710 |
Why?
|
| Purkinje Fibers | 1 | 2021 | 7 | 0.690 |
Why?
|
| Microtubules | 1 | 2022 | 133 | 0.690 |
Why?
|
| Cellular Reprogramming | 2 | 2019 | 129 | 0.680 |
Why?
|
| Cell Fractionation | 1 | 2021 | 22 | 0.670 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 263 | 0.670 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 1207 | 0.660 |
Why?
|
| Cytokinesis | 1 | 2020 | 23 | 0.640 |
Why?
|
| Integrases | 1 | 2021 | 157 | 0.630 |
Why?
|
| Zebrafish | 1 | 2023 | 418 | 0.620 |
Why?
|
| Heart Conduction System | 1 | 2021 | 164 | 0.620 |
Why?
|
| Cellular Reprogramming Techniques | 1 | 2019 | 15 | 0.610 |
Why?
|
| Epigenomics | 1 | 2021 | 181 | 0.610 |
Why?
|
| Humans | 53 | 2026 | 131163 | 0.590 |
Why?
|
| Mice, Transgenic | 8 | 2026 | 2326 | 0.580 |
Why?
|
| Heart Valves | 1 | 2019 | 52 | 0.580 |
Why?
|
| DNA-Binding Proteins | 7 | 2026 | 1939 | 0.580 |
Why?
|
| Premature Birth | 3 | 2019 | 428 | 0.560 |
Why?
|
| Eclampsia | 2 | 2017 | 27 | 0.550 |
Why?
|
| Secretory Vesicles | 1 | 2018 | 20 | 0.550 |
Why?
|
| Pacemaker, Artificial | 1 | 2020 | 193 | 0.550 |
Why?
|
| Obstetrics | 2 | 2017 | 235 | 0.540 |
Why?
|
| Adipogenesis | 1 | 2018 | 82 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 14 | 2026 | 4738 | 0.530 |
Why?
|
| Heart Failure | 4 | 2026 | 2332 | 0.520 |
Why?
|
| Tocolysis | 1 | 2017 | 5 | 0.520 |
Why?
|
| Heart Failure, Systolic | 1 | 2017 | 35 | 0.510 |
Why?
|
| Pericardium | 1 | 2018 | 103 | 0.510 |
Why?
|
| Wound Healing | 2 | 2023 | 490 | 0.500 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2018 | 151 | 0.500 |
Why?
|
| Obstetric Labor, Premature | 1 | 2017 | 76 | 0.500 |
Why?
|
| Heart Ventricles | 4 | 2026 | 749 | 0.480 |
Why?
|
| Sarcomeres | 2 | 2013 | 31 | 0.480 |
Why?
|
| Heart Injuries | 1 | 2016 | 48 | 0.470 |
Why?
|
| Mammals | 3 | 2023 | 253 | 0.470 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 111 | 0.470 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 3436 | 0.470 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 232 | 0.460 |
Why?
|
| Animals, Newborn | 5 | 2026 | 1021 | 0.460 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 238 | 0.460 |
Why?
|
| Phenotype | 3 | 2025 | 4497 | 0.450 |
Why?
|
| Postpartum Period | 1 | 2017 | 245 | 0.450 |
Why?
|
| Mandible | 2 | 2015 | 96 | 0.440 |
Why?
|
| Antioxidants | 3 | 2016 | 331 | 0.440 |
Why?
|
| Embryo, Mammalian | 7 | 2022 | 403 | 0.430 |
Why?
|
| Hypertension, Pregnancy-Induced | 5 | 2017 | 80 | 0.430 |
Why?
|
| Aging | 2 | 2019 | 1242 | 0.420 |
Why?
|
| Face | 1 | 2015 | 192 | 0.420 |
Why?
|
| Cytoskeleton | 1 | 2015 | 166 | 0.410 |
Why?
|
| Transcription, Genetic | 6 | 2020 | 1363 | 0.410 |
Why?
|
| Cellular Senescence | 2 | 2026 | 217 | 0.410 |
Why?
|
| Transgenes | 3 | 2026 | 316 | 0.410 |
Why?
|
| Transcription Factor AP-2 | 1 | 2013 | 22 | 0.400 |
Why?
|
| Disease Models, Animal | 10 | 2025 | 4697 | 0.400 |
Why?
|
| T-Box Domain Proteins | 4 | 2020 | 123 | 0.390 |
Why?
|
| Muscle, Smooth | 1 | 2013 | 116 | 0.390 |
Why?
|
| Heart Defects, Congenital | 3 | 2022 | 1889 | 0.390 |
Why?
|
| Cells, Cultured | 7 | 2026 | 2885 | 0.390 |
Why?
|
| Gene Expression Profiling | 7 | 2025 | 1801 | 0.380 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 72 | 0.380 |
Why?
|
| Patient Safety | 1 | 2017 | 443 | 0.370 |
Why?
|
| Epigenesis, Genetic | 3 | 2025 | 757 | 0.360 |
Why?
|
| Facial Bones | 1 | 2012 | 31 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 325 | 0.340 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2026 | 261 | 0.330 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 407 | 0.330 |
Why?
|
| Pancreas | 2 | 2025 | 217 | 0.330 |
Why?
|
| Cell Division | 3 | 2023 | 718 | 0.320 |
Why?
|
| Ploidies | 2 | 2022 | 35 | 0.320 |
Why?
|
| Cleft Lip | 1 | 2013 | 195 | 0.320 |
Why?
|
| Cleft Palate | 1 | 2013 | 221 | 0.310 |
Why?
|
| Heart Atria | 2 | 2025 | 343 | 0.310 |
Why?
|
| CRISPR-Cas Systems | 3 | 2019 | 317 | 0.310 |
Why?
|
| Hepatocytes | 2 | 2025 | 232 | 0.310 |
Why?
|
| Pregnancy | 15 | 2019 | 7512 | 0.300 |
Why?
|
| Gene Expression | 1 | 2013 | 1481 | 0.290 |
Why?
|
| Stem Cells | 6 | 2019 | 702 | 0.290 |
Why?
|
| Repressor Proteins | 3 | 2022 | 760 | 0.290 |
Why?
|
| Base Sequence | 6 | 2018 | 2730 | 0.280 |
Why?
|
| Swine | 2 | 2023 | 1186 | 0.280 |
Why?
|
| Cell Lineage | 2 | 2021 | 349 | 0.280 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2022 | 254 | 0.270 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2014 | 55 | 0.270 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2323 | 0.260 |
Why?
|
| Gene Deletion | 5 | 2019 | 767 | 0.250 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2026 | 9 | 0.240 |
Why?
|
| Alleles | 3 | 2021 | 1673 | 0.240 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2026 | 19 | 0.240 |
Why?
|
| Gene Editing | 3 | 2025 | 238 | 0.230 |
Why?
|
| Dioxygenases | 2 | 2024 | 69 | 0.230 |
Why?
|
| Microvessels | 1 | 2026 | 58 | 0.230 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2026 | 71 | 0.220 |
Why?
|
| Female | 28 | 2026 | 70963 | 0.220 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2026 | 362 | 0.220 |
Why?
|
| Erythroid Cells | 2 | 2024 | 23 | 0.220 |
Why?
|
| Male | 17 | 2026 | 64957 | 0.220 |
Why?
|
| Genes, Essential | 1 | 2025 | 39 | 0.220 |
Why?
|
| Morphogenesis | 2 | 2018 | 185 | 0.210 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2026 | 150 | 0.210 |
Why?
|
| Endothelium, Vascular | 2 | 2025 | 468 | 0.210 |
Why?
|
| Histidine | 1 | 2024 | 69 | 0.210 |
Why?
|
| Gene Targeting | 1 | 2025 | 169 | 0.210 |
Why?
|
| Apoptosis | 3 | 2022 | 1827 | 0.200 |
Why?
|
| Methylation | 1 | 2024 | 199 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 2 | 2022 | 451 | 0.200 |
Why?
|
| Receptors, Steroid | 2 | 2020 | 167 | 0.200 |
Why?
|
| Oxidative Stress | 4 | 2018 | 791 | 0.200 |
Why?
|
| Methyltransferases | 1 | 2024 | 78 | 0.200 |
Why?
|
| Genetic Vectors | 2 | 2019 | 892 | 0.200 |
Why?
|
| DNA Helicases | 1 | 2025 | 239 | 0.200 |
Why?
|
| Hypertension | 3 | 2017 | 1356 | 0.200 |
Why?
|
| Fatty Acids | 1 | 2026 | 377 | 0.200 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2023 | 56 | 0.190 |
Why?
|
| Cell Line | 3 | 2018 | 2552 | 0.190 |
Why?
|
| Rats | 7 | 2021 | 3370 | 0.190 |
Why?
|
| HeLa Cells | 1 | 2024 | 686 | 0.190 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2013 | 26 | 0.190 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2022 | 12 | 0.180 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 521 | 0.180 |
Why?
|
| Image Cytometry | 1 | 2022 | 18 | 0.180 |
Why?
|
| Embryonic Development | 2 | 2019 | 200 | 0.180 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 2 | 2014 | 9 | 0.180 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 10 | 0.180 |
Why?
|
| RNA, Messenger | 3 | 2017 | 2550 | 0.180 |
Why?
|
| Homocystinuria | 1 | 2022 | 26 | 0.180 |
Why?
|
| Ventricular Function, Left | 1 | 2025 | 549 | 0.170 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 43 | 0.170 |
Why?
|
| Histone Chaperones | 1 | 2021 | 7 | 0.170 |
Why?
|
| Cardiology | 2 | 2017 | 514 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 587 | 0.170 |
Why?
|
| Inflammation | 3 | 2025 | 1489 | 0.170 |
Why?
|
| Oxidoreductases | 1 | 2022 | 105 | 0.170 |
Why?
|
| Thrombosis | 1 | 2026 | 499 | 0.170 |
Why?
|
| Ribosomes | 1 | 2022 | 123 | 0.170 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2021 | 55 | 0.170 |
Why?
|
| Immunomagnetic Separation | 1 | 2021 | 10 | 0.170 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 50 | 0.170 |
Why?
|
| Smad1 Protein | 2 | 2013 | 23 | 0.170 |
Why?
|
| Cyclohexanones | 1 | 2020 | 18 | 0.160 |
Why?
|
| Ventricular Function | 1 | 2021 | 81 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2022 | 235 | 0.160 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 544 | 0.160 |
Why?
|
| Mesoderm | 3 | 2025 | 106 | 0.160 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 187 | 0.160 |
Why?
|
| Mutation, Missense | 1 | 2025 | 919 | 0.160 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 115 | 0.160 |
Why?
|
| Tetralogy of Fallot | 1 | 2022 | 170 | 0.160 |
Why?
|
| Monocytes | 1 | 2022 | 335 | 0.160 |
Why?
|
| Histones | 2 | 2021 | 541 | 0.160 |
Why?
|
| Child | 3 | 2025 | 26341 | 0.160 |
Why?
|
| Developed Countries | 2 | 2017 | 43 | 0.160 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 155 | 0.150 |
Why?
|
| Anemia | 1 | 2024 | 354 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 378 | 0.150 |
Why?
|
| Tamoxifen | 1 | 2021 | 348 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 371 | 0.150 |
Why?
|
| Placenta Growth Factor | 1 | 2019 | 15 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 160 | 0.150 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2019 | 3 | 0.150 |
Why?
|
| YY1 Transcription Factor | 1 | 2019 | 17 | 0.150 |
Why?
|
| Endoderm | 1 | 2019 | 24 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2019 | 21 | 0.150 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2019 | 31 | 0.150 |
Why?
|
| Triage | 2 | 2017 | 144 | 0.150 |
Why?
|
| Saccule and Utricle | 1 | 2019 | 9 | 0.150 |
Why?
|
| Autoantibodies | 2 | 2014 | 451 | 0.150 |
Why?
|
| Pyridines | 1 | 2020 | 255 | 0.150 |
Why?
|
| Diploidy | 1 | 2019 | 40 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2019 | 597 | 0.140 |
Why?
|
| Trans-Activators | 3 | 2019 | 697 | 0.140 |
Why?
|
| Hair Cells, Auditory | 1 | 2019 | 64 | 0.140 |
Why?
|
| Gene Regulatory Networks | 4 | 2025 | 373 | 0.140 |
Why?
|
| Electron Transport Complex IV | 1 | 2018 | 42 | 0.140 |
Why?
|
| Action Potentials | 2 | 2019 | 476 | 0.140 |
Why?
|
| Transcription Factor AP-1 | 1 | 2019 | 110 | 0.140 |
Why?
|
| Mutation | 7 | 2022 | 6099 | 0.140 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2018 | 20 | 0.140 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2018 | 24 | 0.140 |
Why?
|
| Cardiomegaly | 1 | 2019 | 117 | 0.140 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 115 | 0.140 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2018 | 22 | 0.140 |
Why?
|
| Binding Sites | 1 | 2021 | 1133 | 0.140 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3464 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 223 | 0.130 |
Why?
|
| Olfactory Bulb | 1 | 2018 | 82 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2017 | 3711 | 0.130 |
Why?
|
| Heart Rate | 1 | 2020 | 577 | 0.130 |
Why?
|
| Blood Pressure | 3 | 2012 | 1345 | 0.130 |
Why?
|
| Quality Control | 1 | 2017 | 116 | 0.130 |
Why?
|
| Fetal Heart | 1 | 2018 | 132 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2022 | 690 | 0.130 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 47 | 0.130 |
Why?
|
| Regenerative Medicine | 1 | 2017 | 39 | 0.130 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 154 | 0.130 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1046 | 0.130 |
Why?
|
| Neuroglia | 1 | 2019 | 224 | 0.130 |
Why?
|
| Heart-Assist Devices | 1 | 2026 | 1020 | 0.130 |
Why?
|
| Health Priorities | 1 | 2017 | 42 | 0.120 |
Why?
|
| Neurogenesis | 1 | 2018 | 206 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2018 | 587 | 0.120 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 645 | 0.120 |
Why?
|
| Sumoylation | 1 | 2017 | 47 | 0.120 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2017 | 110 | 0.120 |
Why?
|
| Critical Pathways | 1 | 2017 | 76 | 0.120 |
Why?
|
| Electron Transport | 1 | 2016 | 60 | 0.120 |
Why?
|
| Cardiotoxicity | 1 | 2016 | 49 | 0.120 |
Why?
|
| Women's Health | 1 | 2017 | 134 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 198 | 0.120 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 54 | 0.120 |
Why?
|
| Health Services Research | 1 | 2017 | 180 | 0.120 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2016 | 21 | 0.120 |
Why?
|
| Embryo Loss | 1 | 2015 | 20 | 0.120 |
Why?
|
| Retina | 1 | 2019 | 425 | 0.120 |
Why?
|
| Disease Progression | 1 | 2022 | 2200 | 0.120 |
Why?
|
| Prenatal Care | 1 | 2018 | 345 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2017 | 173 | 0.120 |
Why?
|
| Adult | 3 | 2025 | 31282 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 227 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2018 | 502 | 0.110 |
Why?
|
| Outpatients | 1 | 2017 | 262 | 0.110 |
Why?
|
| Emergency Medicine | 1 | 2017 | 172 | 0.110 |
Why?
|
| Placenta | 4 | 2014 | 504 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 143 | 0.110 |
Why?
|
| Mice, Inbred mdx | 1 | 2015 | 46 | 0.110 |
Why?
|
| RNA Interference | 2 | 2014 | 491 | 0.110 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 137 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 354 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2015 | 161 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2015 | 78 | 0.110 |
Why?
|
| Albinism | 1 | 2014 | 8 | 0.110 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2014 | 9 | 0.110 |
Why?
|
| Medical Oncology | 1 | 2016 | 245 | 0.110 |
Why?
|
| Genome | 1 | 2017 | 451 | 0.110 |
Why?
|
| Monophenol Monooxygenase | 1 | 2014 | 23 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 2121 | 0.110 |
Why?
|
| Pigmentation | 1 | 2014 | 37 | 0.100 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 171 | 0.100 |
Why?
|
| Cell Physiological Phenomena | 1 | 2014 | 16 | 0.100 |
Why?
|
| Liver | 2 | 2025 | 1796 | 0.100 |
Why?
|
| Endonucleases | 1 | 2014 | 54 | 0.100 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 149 | 0.100 |
Why?
|
| Progestins | 1 | 2014 | 39 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2012 | 86 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2017 | 401 | 0.100 |
Why?
|
| Reproduction | 1 | 2015 | 210 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 612 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2015 | 257 | 0.100 |
Why?
|
| SOX9 Transcription Factor | 1 | 2014 | 82 | 0.100 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2013 | 19 | 0.100 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 178 | 0.100 |
Why?
|
| Hydrocephalus | 1 | 2015 | 245 | 0.100 |
Why?
|
| Mullerian Ducts | 1 | 2013 | 44 | 0.100 |
Why?
|
| Models, Biological | 1 | 2018 | 1371 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 237 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 1211 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 150 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 614 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 1075 | 0.090 |
Why?
|
| Environmental Exposure | 1 | 2015 | 298 | 0.090 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2014 | 242 | 0.090 |
Why?
|
| Neural Tube Defects | 1 | 2015 | 330 | 0.090 |
Why?
|
| Mosaicism | 1 | 2014 | 248 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 1833 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2014 | 1105 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2015 | 487 | 0.090 |
Why?
|
| beta Catenin | 1 | 2013 | 197 | 0.090 |
Why?
|
| Pregnancy, Animal | 1 | 2012 | 66 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2014 | 412 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2012 | 125 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 330 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 664 | 0.090 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 414 | 0.090 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 71 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2012 | 582 | 0.080 |
Why?
|
| Risk Factors | 4 | 2018 | 11074 | 0.080 |
Why?
|
| Epithelium | 2 | 2013 | 335 | 0.080 |
Why?
|
| Calcium | 1 | 2014 | 1010 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 388 | 0.080 |
Why?
|
| Child, Preschool | 1 | 2025 | 15110 | 0.070 |
Why?
|
| Uterus | 1 | 2013 | 541 | 0.070 |
Why?
|
| Adolescent | 2 | 2025 | 20987 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2013 | 905 | 0.070 |
Why?
|
| Neurons | 1 | 2018 | 1979 | 0.070 |
Why?
|
| Serum Response Factor | 1 | 2008 | 30 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 953 | 0.070 |
Why?
|
| Muscle Development | 2 | 2008 | 72 | 0.070 |
Why?
|
| Ovary | 2 | 2007 | 345 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2008 | 229 | 0.070 |
Why?
|
| Spleen | 2 | 2024 | 258 | 0.070 |
Why?
|
| Smad5 Protein | 1 | 2007 | 20 | 0.070 |
Why?
|
| Ischemia | 1 | 2011 | 359 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2018 | 12936 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 639 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 127 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1826 | 0.060 |
Why?
|
| Decidua | 1 | 2007 | 143 | 0.060 |
Why?
|
| Branchial Region | 1 | 2005 | 9 | 0.060 |
Why?
|
| Testis | 1 | 2007 | 389 | 0.060 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2025 | 16 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 713 | 0.050 |
Why?
|
| Hydrolases | 1 | 2025 | 61 | 0.050 |
Why?
|
| Mitochondria, Heart | 1 | 2025 | 58 | 0.050 |
Why?
|
| Arteries | 1 | 2005 | 208 | 0.050 |
Why?
|
| Extremities | 1 | 2004 | 73 | 0.050 |
Why?
|
| Atrial Appendage | 1 | 2025 | 77 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2025 | 394 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2026 | 8635 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2025 | 3359 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 266 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2025 | 133 | 0.050 |
Why?
|
| Mitochondrial Diseases | 1 | 2025 | 158 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2018 | 765 | 0.050 |
Why?
|
| Biomarkers | 3 | 2019 | 3385 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 801 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2018 | 437 | 0.050 |
Why?
|
| Metabolomics | 1 | 2026 | 501 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 18 | 0.040 |
Why?
|
| Spin Labels | 2 | 2012 | 24 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2014 | 825 | 0.040 |
Why?
|
| Cyclic N-Oxides | 2 | 2012 | 19 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 59 | 0.040 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 70 | 0.040 |
Why?
|
| DNA Repair | 1 | 2025 | 571 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2021 | 50 | 0.040 |
Why?
|
| United States | 1 | 2017 | 12072 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2022 | 157 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2021 | 57 | 0.040 |
Why?
|
| Neoplasms | 1 | 2016 | 3016 | 0.040 |
Why?
|
| Brain | 2 | 2025 | 3175 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2026 | 804 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2021 | 48 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2015 | 222 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 51 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 49 | 0.040 |
Why?
|
| Iron | 1 | 2024 | 304 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 889 | 0.040 |
Why?
|
| DNA Demethylation | 1 | 2019 | 11 | 0.040 |
Why?
|
| Infertility, Female | 2 | 2013 | 145 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 213 | 0.040 |
Why?
|
| Cyclin D3 | 1 | 2019 | 11 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2019 | 63 | 0.040 |
Why?
|
| Perinatal Death | 1 | 2019 | 29 | 0.040 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2019 | 70 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2019 | 106 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2019 | 161 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 569 | 0.040 |
Why?
|
| North America | 1 | 2019 | 255 | 0.040 |
Why?
|
| Cochlea | 1 | 2019 | 85 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 224 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 138 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 981 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 276 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 195 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 344 | 0.030 |
Why?
|
| RNA | 1 | 2020 | 517 | 0.030 |
Why?
|
| Interneurons | 1 | 2018 | 146 | 0.030 |
Why?
|
| Time Factors | 2 | 2019 | 6196 | 0.030 |
Why?
|
| Slovenia | 1 | 2016 | 2 | 0.030 |
Why?
|
| Czech Republic | 1 | 2016 | 11 | 0.030 |
Why?
|
| Sweden | 1 | 2016 | 39 | 0.030 |
Why?
|
| New Zealand | 1 | 2016 | 63 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2017 | 142 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2017 | 106 | 0.030 |
Why?
|
| Telomere Shortening | 1 | 2016 | 33 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 667 | 0.030 |
Why?
|
| California | 1 | 2016 | 127 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 15 | 0.030 |
Why?
|
| International Agencies | 1 | 2015 | 28 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1224 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 449 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 351 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2015 | 99 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 265 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 761 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2825 | 0.030 |
Why?
|
| Melanins | 1 | 2014 | 18 | 0.030 |
Why?
|
| RNA, Small Untranslated | 1 | 2014 | 20 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 2085 | 0.030 |
Why?
|
| Zygote | 1 | 2014 | 28 | 0.030 |
Why?
|
| Nitrates | 1 | 2014 | 29 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 464 | 0.030 |
Why?
|
| Nitrites | 1 | 2014 | 48 | 0.030 |
Why?
|
| RNA Stability | 1 | 2014 | 77 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 191 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 2304 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2015 | 240 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2015 | 297 | 0.020 |
Why?
|
| Myometrium | 1 | 2013 | 47 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2014 | 324 | 0.020 |
Why?
|
| Lipids | 1 | 2017 | 569 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2014 | 341 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 186 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1378 | 0.020 |
Why?
|
| Protein Stability | 1 | 2013 | 165 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 1077 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2014 | 243 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 356 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 700 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 645 | 0.020 |
Why?
|
| Isoprostanes | 1 | 2012 | 4 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 419 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 962 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 60 | 0.020 |
Why?
|
| Losartan | 1 | 2012 | 36 | 0.020 |
Why?
|
| Aged | 2 | 2025 | 21025 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 110 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 915 | 0.020 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2012 | 56 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 316 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1240 | 0.020 |
Why?
|
| Rituximab | 1 | 2012 | 170 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 44 | 0.020 |
Why?
|
| Sarcoma | 1 | 2013 | 219 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2012 | 190 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2011 | 109 | 0.020 |
Why?
|
| Global Health | 1 | 2015 | 626 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1571 | 0.020 |
Why?
|
| Endometrium | 1 | 2013 | 292 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 533 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2009 | 41 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 509 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 928 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 787 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 450 | 0.020 |
Why?
|
| GATA6 Transcription Factor | 1 | 2008 | 10 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2009 | 118 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2008 | 79 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 1692 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6459 | 0.020 |
Why?
|
| Smad8 Protein | 1 | 2007 | 5 | 0.020 |
Why?
|
| Sertoli Cell Tumor | 1 | 2007 | 7 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 157 | 0.020 |
Why?
|
| Granulosa Cell Tumor | 1 | 2007 | 38 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 223 | 0.020 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2007 | 68 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 28601 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 121 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2007 | 112 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2007 | 191 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 197 | 0.010 |
Why?
|
| Pharynx | 1 | 2005 | 69 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 263 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 2007 | 218 | 0.010 |
Why?
|
| Fertility | 1 | 2007 | 260 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 10103 | 0.010 |
Why?
|
| COUP Transcription Factors | 1 | 2004 | 30 | 0.010 |
Why?
|
| Cytokines | 1 | 2011 | 1339 | 0.010 |
Why?
|
| Blastocyst | 1 | 2004 | 73 | 0.010 |
Why?
|
| COUP Transcription Factor II | 1 | 2004 | 99 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 749 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2005 | 435 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 533 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1591 | 0.010 |
Why?
|
| Cell Movement | 1 | 2004 | 876 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 530 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 2026 | 0.010 |
Why?
|